- 全部删除
您的购物车当前为空
KL-11743 是葡萄糖竞争性 I 类葡萄糖转运蛋白抑制剂,口服有活性,能够抑制GLUT1 (IC50:115 nM) 、GLUT2 (IC50:137 nM) 、GLUT3 (IC50:90 nM) 及GLUT4 (IC50:68 nM) 。它能够特异性阻断葡萄糖代谢,也可与电子传递抑制剂协同作用诱导细胞死亡。


为众多的药物研发团队赋能,
让新药发现更简单!
KL-11743 是葡萄糖竞争性 I 类葡萄糖转运蛋白抑制剂,口服有活性,能够抑制GLUT1 (IC50:115 nM) 、GLUT2 (IC50:137 nM) 、GLUT3 (IC50:90 nM) 及GLUT4 (IC50:68 nM) 。它能够特异性阻断葡萄糖代谢,也可与电子传递抑制剂协同作用诱导细胞死亡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 923 | In stock | |
| 5 mg | ¥ 2,470 | In stock | |
| 10 mg | ¥ 3,980 | In stock | |
| 25 mg | ¥ 6,370 | In stock | |
| 50 mg | ¥ 8,730 | In stock | |
| 100 mg | ¥ 11,700 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,730 | In stock |
KL-11743 相关产品
| 产品描述 | KL-11743 specifically blocks glucose metabolism, triggering an acute collapse in NADH pools and a striking accumulation of aspartate, indicating a dramatic shift toward oxidative phosphorylation in the mitochondria. |
| 靶点活性 | GLUT2:137 nM (IC50), GLUT1:115 nM (IC50), GLUT3:90 nM (IC50), GLUT4:68 nM (IC50) |
| 体外活性 | 患者源性异种移植瘤模型中,缺乏琥珀酸脱氢酶A(SDHA)的癌症对KL-11743特别敏感,直接证明了TCA循环突变肿瘤在体内对GLUT抑制剂易感[1]。 |
| 分子量 | 522.6 |
| 分子式 | C30H30N6O3 |
| CAS No. | 1369452-53-8 |
| Smiles | CCOc1ccc2nc(nc(Nc3ccc(cc3)-c3cn[nH]c3)c2c1)-c1cccc(OCC(=O)NC(C)C)c1 |
| 密度 | 1.259 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (47.84 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容